Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.01)
# 527
Out of 5,242 analysts
326
Total ratings
42.12%
Success rate
14.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $26.42 | +89.25% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $2.93 | +309.56% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $300.51 | +89.68% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $11.59 | +245.13% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $4.33 | +246.42% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $21.54 | -53.57% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.11 | +350.45% | 19 | Jun 26, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.49 | +1,055.62% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $30.00 | +233.33% | 21 | Jun 2, 2025 | |
| QURE uniQure | Reiterates: Buy | $70 | $24.76 | +182.71% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.79 | +532.91% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.16 | +737.99% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $75.54 | +5.90% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $21.77 | +83.74% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.68 | +715.22% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $30.49 | +129.58% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $27.67 | +189.12% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.52 | +557.89% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.2009 | +4,877.60% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $9.03 | +1,118.16% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $83.24 | +2.11% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $11.40 | +496.49% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $76.26 | +345.84% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $26.42
Upside: +89.25%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $2.93
Upside: +309.56%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $300.51
Upside: +89.68%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $11.59
Upside: +245.13%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.33
Upside: +246.42%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $21.54
Upside: -53.57%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.11
Upside: +350.45%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.49
Upside: +1,055.62%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $30.00
Upside: +233.33%
uniQure
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $24.76
Upside: +182.71%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.79
Upside: +532.91%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $7.16
Upside: +737.99%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $75.54
Upside: +5.90%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $21.77
Upside: +83.74%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.68
Upside: +715.22%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $30.49
Upside: +129.58%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $27.67
Upside: +189.12%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.52
Upside: +557.89%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.2009
Upside: +4,877.60%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $9.03
Upside: +1,118.16%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $83.24
Upside: +2.11%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $11.40
Upside: +496.49%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $76.26
Upside: +345.84%